Area of research
Hematology · Cancer Research
Research interest
Research interests include Open label, Stroke (engine), Medicine, Ischaemic stroke, and Clinical trial.
Discovery of HZS60 as a Novel Brain Penetrant NMDAR/TRPM4 Interaction Interface Inhibitor with Improved Activity and Pharmacokinetic Properties for the Treatment of Cerebral Ischemia
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
Segmentation of infarct lesions and prognosis prediction for acute ischemic stroke using non-contrast CT scans